Actively Recruiting
Hypofractionated Radiotherapy for Thymic Epithelial Tumors
Led by Rongrong Zhou · Updated on 2024-11-18
100
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if hypofractionated radiotherapy works to shorten the treatment time without increasing the side effects in patients of thymic epithelial tumors. The main questions it aims to answer are: * Does Hypofractionated radiotherapy provide better results? * Can hypofractionated radiotherapy reduce toxic and side effects compared with conventional radiotherapy? Researchers will compare the efficacy and safety of hypofractionated radiotherapy after thymic tumor surgery. Participants will: * Receive hypofractionated radiotherapy or conventional radiotherapy * Visit the hospital regularly once every 12 weeks for checkups and tests
CONDITIONS
Official Title
Hypofractionated Radiotherapy for Thymic Epithelial Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must provide written informed consent.
- Age between 18 and less than 75 years.
- Pathologically confirmed thymoma (types A, AB, B1, B2, B3) or thymic carcinoma.
- Masaoka-Koga stage I to III.
- ECOG performance status of 0 to 2.
- Expected survival time greater than 1 year.
- Women of childbearing age must have a negative pregnancy test and agree to use effective contraception during the trial.
- Patients must not be lactating.
- Sufficient bone marrow function and good major organ function.
You will not qualify if you...
- Prior thoracic radiotherapy.
- Conditions unsuitable for radiotherapy, such as recent myocardial infarction or active congestive heart failure.
- Uncontrolled infections or serious medical or mental illnesses that interfere with care.
- Other malignant tumors not under stable control.
- Known history of mental illness, substance abuse, alcohol or drug abuse.
- Other conditions considered unsuitable for enrollment by the attending physician.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xiangya Hospital, Central South University
Changsha, Hunan, China, 410000
Actively Recruiting
Research Team
R
Rongrong Zhou, MD, PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here